<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 63-year-old woman was referred to our division because of massive <z:hpo ids='HP_0002105'>hemoptysis</z:hpo> (200 ml) after administration of <z:chebi fb="0" ids="9588">ticlopidine</z:chebi>, an anti-thrombotic drug, for prevention of recurrent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="9588">Ticlopidine</z:chebi> treatment was stopped on the first hospital day, thereafter the patient's <z:hpo ids='HP_0002105'>hemoptysis</z:hpo> immediately disappeared </plain></SENT>
<SENT sid="2" pm="."><plain>A chest roentgenogram and broncho-fiberscopic examination did not reveal any organic lesion associated with <z:hpo ids='HP_0002105'>hemoptysis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Laboratory data revealed <z:hpo ids='HP_0003010'>prolonged bleeding time</z:hpo> and <z:mp ids='MP_0009549'>decreased platelet aggregation</z:mp>, suggesting that the patient had had a <z:e sem="disease" ids="C0019087" disease_type="Disease or Syndrome" abbrv="">hemorrhagic diathesis</z:e> associated with the administration of <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Although many anti-thrombotic drugs have been recently employed in a variety of clinical cases, the patient's <z:hpo ids='HP_0002105'>hemoptysis</z:hpo> was considered to be due to side effects </plain></SENT>
</text></document>